What is Flownamics?
Flownamics operates at the intersection of advanced engineering and life sciences, specializing in the design and deployment of automated sampling systems and bioprocess automation solutions. With a legacy spanning over three decades, the company has become a cornerstone for organizations seeking to optimize both upstream and downstream workflows. Their flagship product portfolio, which includes the Seg-Flow sampling systems and sophisticated biochemistry analyzers, addresses the growing demand for data-driven accuracy in complex biological environments. By bridging the gap between manual laboratory processes and fully automated production environments, Flownamics enables researchers and manufacturers to achieve unprecedented levels of consistency and operational throughput.
How much funding has Flownamics raised?
Flownamics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Flownamics
PPP
Public-Private Partnership
What's next for Flownamics?
With this late-stage capital injection, Flownamics is well-positioned to accelerate its market expansion and deepen its technological moat. The strategic focus will likely center on scaling the adoption of its automated dispensing systems and enhancing the integration capabilities of its existing analytical platforms. As the bioprocess industry continues to prioritize digital transformation and real-time monitoring, Flownamics is poised to leverage its deep domain expertise to capture additional market share. The company's trajectory suggests a move toward broader international deployment and the potential for further innovation in high-throughput bioprocessing, ensuring that their solutions remain at the forefront of the global biotechnology supply chain.
See full Flownamics company page
